Rising ELISPOT count prior to the onset of symptoms of full-blown tuberculosis disease

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 3, 2007, Pages 350-352

  Adetifa, Ifedayo M O ^a   Brookes, R ^a   Lugos, M D ^a   De Jong, B C ^a   Antonio, M ^a   Adegbola, R A ^a   Hill, P C ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

ELISPOT; Mycobacterium tuberculosis; Tuberculin skin test; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ANOREXIA; ARTICLE; BACTERIUM CULTURE; BCG VACCINATION; CASE REPORT; DISEASE COURSE; ENZYME LINKED IMMUNOSPOT ASSAY; FEVER; HUMAN; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYMPTOM; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MALE; MIDDLE AGED; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 33947396019     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Hill P C, Brookes R, Fox A, et al. Large-scale evaluation of ELISPOT assay and skin test for the diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis 2004; 38: 966-973.
2. Jeffries D J, Hill P C, Fox A, et al. Determination of ELISPOT assay and PPD skin test cut-offs for the diagnosis of Mycobacterium tuberculosis in The Gambia. Int J Tuberc Lung Dis 2006; 10: 192-198.
3. van Embden J D, Cave M D, Crawford J T, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-409.
4. Hill P C, Fox A, Jeffries D J, et al. Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clin Infect Dis 2005; 40: 273-278.
5. Doherty T M, Demissie A, Olobo J, et al. Immune reaponses to Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts to tuberculosis patients. J Clin Microbiol 2002; 40: 704-706.
6. Vordermeier H M, Chambers M A, Cockle P J, et al. Correlation of ESAT-6-specific gamma interferon gamma production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun 2002; 70: 3026-3032.
7. Langhermans J A M, Doherty T M, Vervenne R A W, et al. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine 2005; 23: 2740-2750.
8. Vekemans J, Lienhardt C, Sillah J S, et al. Tuberculosis contacts but not patients have higher gamma-interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun 2001; 69: 6554-6557.
9. Nicol M P, Pienaar D, Wood K, et al. Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin Infect Dis 2005; 40: 1301-1308.
10. Carrara S, Vinceti D, Petrosillo N, et al. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 2004; 38: 754-756.